GlassScriptPhysician profile
Gayle Fenner
NPI 1255720025
$1,328.58
in general payments reported to CMS, 2019-2025
13 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.21 · 2022: $332 · 2023: $237 · 2024: $501 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $343.29 | 2022-2025 | Evo Retrograde, Anthem, Autobahn |
| Bioventus LLC | $296.19 | 2021-2025 | Durolane, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Evolution Surgical, INC | $205.23 | 2024-2025 | |
| Amgen INC. | $120.61 | 2022 | |
| Orthofix Medical, INC. | $63.22 | 2023-2024 | Physio-Stim, Accelstim |
| Molnlycke Health Care US, LLC | $61.49 | 2024-2025 | Avance, Mepilex Border Post-Op Ag, Mepilex Ag |
| Acera Surgical, INC. | $54.01 | 2023-2025 | Restrata Wound Matrix |
| Stryker Corporation | $53.34 | 2024 | Variax |
| Encore Medical, LP | $45.40 | 2022 | |
| Teleflex LLC | $30.32 | 2024 | Quikclot |
| Si-Bone, INC. | $21.37 | 2022 | |
| Integra Lifesciences Corporation | $20.89 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Trevena, INC. | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gayle Fenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.